Can you create a comprehensive mind map of ischemic stroke, covering modifiable and non‑modifiable risk factors, pathophysiology, clinical presentation, diagnostic work‑up, acute management, secondary prevention, complications, and rehabilitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Comprehensive Mind Map of Ischemic Stroke

I. DEFINITIONS & CLASSIFICATION

Ischemic stroke is defined as focal brain injury with symptoms lasting >24 hours or imaging evidence of acute infarction, while TIA represents transient neurological dysfunction from focal brain/spinal cord/retinal ischemia without acute infarction 1.

Stroke Subtypes by Mechanism 1, 2:

  • Large-artery atherosclerosis (20%): Extracranial or intracranial carotid/vertebrobasilar disease
  • Cardioembolic (20%): Most commonly from atrial fibrillation
  • Small-vessel disease (25%): Lacunar/subcortical strokes from penetrating artery disease
  • Other determined causes: Dissection, hypercoagulable states, sickle cell disease
  • Cryptogenic (30%): Undetermined cause despite workup

II. RISK FACTORS

A. Non-Modifiable Risk Factors 3, 2:

  • Age: Risk increases exponentially with advancing age
  • Sex: Women experience 60,000 more strokes annually than men
  • Race/Ethnicity:
    • American Indian/Alaskan Native: 6.7% prevalence (highest)
    • Black men and women: 4.0% prevalence (twice that of whites)
    • Hispanic/Latino: 3.1% men, 1.9% women
  • Prior TIA: 90-day stroke risk up to 17%, greatest in first week 1
  • Genetic factors

B. Modifiable Risk Factors 1, 4:

Hypertension (Most Important):

  • Present in 72 million Americans (SBP ≥140 or DBP ≥90 mmHg)
  • Continuous association with stroke risk starting at SBP 115 mmHg
  • BP lowering reduces stroke risk by 30-40% 1

Other Major Modifiable Factors:

  • Diabetes mellitus
  • Atrial fibrillation
  • Dyslipidemia
  • Cigarette smoking
  • Physical inactivity
  • Obesity
  • Excessive alcohol consumption
  • Carotid stenosis
  • Left ventricular hypertrophy

III. PATHOPHYSIOLOGY 5:

The ischemic cascade involves multiple interconnected mechanisms:

  1. Energy deficiency: Loss of ATP production
  2. Ion homeostasis disruption: Calcium influx, sodium/potassium imbalance
  3. Oxidative stress: Free radical generation
  4. Neuroinflammation: Microglial activation, cytokine release
  5. Blood-brain barrier disruption: Vasogenic edema
  6. Programmed cell death: Apoptosis, necrosis, autophagy
  7. Cerebral edema: Cytotoxic and vasogenic components

IV. CLINICAL PRESENTATION

Acute Symptoms (Depend on Vascular Territory):

  • Sudden onset focal neurological deficits
  • Hemiparesis/hemiplegia
  • Facial droop
  • Speech disturbances (aphasia, dysarthria)
  • Visual field defects
  • Sensory loss
  • Ataxia/coordination problems
  • Altered consciousness (in severe cases)

Critical Time Point:

"Last known well time" is the single most important determinant of treatment eligibility 2


V. DIAGNOSTIC WORK-UP

A. Immediate Imaging 6, 1:

For IV tPA candidates (0-4.5 hour window):

  • Noncontrast CT OR MRI (DWI, FLAIR, GRE/SWI) to exclude hemorrhage and assess ischemic extent

For endovascular therapy candidates:

  • Vascular imaging strongly recommended: CTA, MRA, or conventional angiography during initial evaluation 6

MRI with DWI is the most sensitive imaging technique for early ischemic changes 7

B. Minimum Required Evaluation 1:

  • Brain imaging (CT or MRI) to distinguish ischemic from hemorrhagic stroke
  • Vascular imaging of head and neck to evaluate mechanism and future risk 6
  • Evaluation to exclude high-risk conditions:
    • Carotid stenosis
    • Atrial fibrillation
  • Echocardiography for cardiac sources

VI. ACUTE MANAGEMENT

A. Blood Pressure Management 8, 9:

For patients NOT receiving reperfusion therapy:

  • Do NOT actively lower BP if <220/120 mmHg in first 48-72 hours (not effective for preventing death/dependency)
  • Spontaneous BP lowering occurs in ~75% of patients naturally 8

For IV thrombolysis candidates:

  • Pre-treatment target: <185/110 mmHg
  • Maintain <180/105 mmHg during first 24 hours 8
  • Post-thrombolysis: Maintain SBP 140-180 mmHg (reduces ICH without improving outcomes at lower targets) 8

For endovascular therapy candidates:

  • Pre-procedure: <185/110 mmHg 8
  • Post-EVT: Avoid intensive lowering to <140 mmHg (leads to lower functional independence and higher mortality) 8

B. Reperfusion Therapy:

IV Thrombolysis (rtPA/Alteplase):

  • 0-4.5 hour window from last known well time
  • Requires BP <185/110 mmHg before treatment 8

Endovascular Therapy (Mechanical Thrombectomy):

  • Extended time windows (up to 8+ hours with appropriate imaging selection)
  • Requires vascular imaging to confirm large vessel occlusion 6

C. Early Mobilization 10:

Graduated early mobilization initiated between 24-48 hours post-stroke is recommended 10

AVOID very early mobilization (<24 hours):

  • Associated with decreased odds of favorable 3-month outcomes
  • Especially harmful in patients with:
    • Worse NIHSS scores
    • Intracerebral hemorrhage
    • Impaired consciousness
    • Higher intensity/frequency sessions 10

VII. SECONDARY PREVENTION

A. Blood Pressure Control 1, 9:

Long-term target: <130/80 mmHg 9

  • Greater BP reductions = greater stroke risk reduction
  • No clear drug class-specific advantage 1

Preferred agents:

  • Thiazide diuretics
  • ACE inhibitors
  • Angiotensin receptor blockers
  • Calcium channel blockers 9

B. Antiplatelet Therapy 11:

For noncardioembolic stroke:

  • Dual antiplatelet therapy (aspirin + clopidogrel) for 21-90 days for minor strokes and high-risk TIA
  • Convert to single antiplatelet therapy after initial period 11

For cardioembolic stroke:

  • Long-term anticoagulation required
  • Direct oral anticoagulants (DOACs) preferred over warfarin for nonvalvular atrial fibrillation 11

C. Lipid Management:

  • Statin therapy for atherosclerotic disease
  • Target LDL reduction

D. Diabetes Management:

  • Glycemic control optimization

E. Lifestyle Modifications 1, 4:

  • Weight loss if overweight
  • Diet rich in fruits, vegetables, low-fat dairy
  • Regular aerobic physical activity
  • Limited alcohol consumption
  • Smoking cessation

F. Carotid Revascularization:

  • For significant carotid stenosis (≥50-70% symptomatic)

VIII. COMPLICATIONS

Acute Phase (First 72 hours) 2:

  • Cerebral edema
  • Hemorrhagic transformation
  • Seizures
  • Aspiration pneumonia
  • Deep vein thrombosis
  • Pressure ulcers
  • Neurological deterioration

Chronic Sequelae 11:

  • Mobility/balance impairments
  • Cognitive deficits
  • Dysphagia
  • Poststroke depression (common and undertreated)
  • Chronic pain
  • Spasticity

IX. REHABILITATION 10, 11:

Multidisciplinary approach is essential:

A. Physical Therapy:

  • Mobility training
  • Balance exercises
  • Gait training
  • Strength building

B. Occupational Therapy:

  • Activities of daily living retraining
  • Adaptive equipment training
  • Upper extremity function

C. Speech Therapy:

  • Aphasia treatment
  • Dysphagia management
  • Cognitive-communication therapy

D. Prevention of Complications 10:

  • Regular skin assessments using valid measurement instruments during acute hospitalization and post-acute care
  • Positioning protocols
  • Early mobilization (24-48 hours)
  • Contracture prevention

E. Psychosocial Support:

  • Depression screening and treatment
  • Caregiver education
  • Community reintegration planning

X. PHASES OF CARE 2:

Phase 1 (Hyperacute/Emergency): 0-24 hours

  • Identify stroke symptoms and location
  • Determine last known well time
  • Assess for reperfusion therapy eligibility
  • Initiate acute treatment

Phase 2 (Acute): 24-72 hours

  • Clarify stroke mechanism
  • Prevent medical complications
  • Begin secondary prevention
  • Prepare for discharge planning

Phase 3 (Subacute/Rehabilitation): Beyond 72 hours

  • Intensive rehabilitation
  • Optimize secondary prevention
  • Address chronic complications
  • Long-term follow-up

XI. CRITICAL PITFALLS TO AVOID

  1. Delaying imaging: Time is brain—immediate CT/MRI is mandatory
  2. Aggressive BP lowering in acute phase: Harmful unless >220/120 mmHg or receiving reperfusion therapy 8
  3. Very early mobilization (<24 hours): Associated with worse outcomes 10
  4. Missing atrial fibrillation: Requires anticoagulation, not antiplatelet therapy
  5. Inadequate long-term BP control: Target <130/80 mmHg for secondary prevention 9
  6. Undertreating depression: Common and significantly impacts recovery 11
  7. Premature discontinuation of dual antiplatelet therapy: Continue for full 21-90 days in appropriate patients 11

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.